Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation.
暂无分享,去创建一个
J. Ciezki | C. Reddy | E. Klein | A. Vassil | J. Ulchaker | E. Murphy | K. Angermeier | A. Altman | N. Chehade
[1] J. Ciezki,et al. Outcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy? , 2009, Urologic oncology.
[2] W. Sega,et al. Laparoscopic extended pelvic lymph node dissection for prostate cancer: description of the surgical technique and initial results. , 2007, European urology.
[3] G. Lockwood,et al. Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer. , 2009, International journal of radiation oncology, biology, physics.
[4] M. Kattan,et al. The surgical learning curve for prostate cancer control after radical prostatectomy. , 2007, Journal of the National Cancer Institute.
[5] Charles R. Thomas,et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. , 2007, International journal of radiation oncology, biology, physics.
[6] M. Cooperberg,et al. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). , 2003, The Journal of urology.
[7] S. Stokes,et al. Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation. , 2000, International journal of radiation oncology, biology, physics.
[8] H. Sandler,et al. Hormone therapy and radiotherapy for intermediate risk prostate cancer. , 2008, Seminars in radiation oncology.
[9] Utilization and outcomes of minimally invasive radical prostatectomy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] A. Renshaw,et al. Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .
[11] T. Keane,et al. Pathologically confirmed port site metastasis after laparoscopic radical prostatectomy: case report and literature review. , 2007, Urology.
[12] L. Wilson,et al. Surgery Versus Implant for Early Prostate Cancer: Results From a Single Institution, 1992–2005 , 2007, Cancer journal.
[13] P. Scardino,et al. An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow‐up , 2002, Cancer.
[14] X. Cathelineau,et al. Impact of learning curve in laparoscopic radical prostatectomy on margin status: prospective study of first 100 procedures performed by one surgeon. , 2004, Journal of endourology.
[15] M. Kattan,et al. Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] J. Cadeddu,et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy: Reply by authors , 1998 .
[17] J. Ciezki,et al. The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment. , 2010, Urology.
[18] Kirsten L. Greene,et al. Who is the average patient presenting with prostate cancer? , 2005, Urology.
[19] J. Manola,et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. , 2004, JAMA.
[20] J. Ciezki,et al. A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy. , 2004, International journal of radiation oncology, biology, physics.
[21] Michael W Kattan,et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. Cadeddu,et al. Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy. , 1998, The Journal of urology.
[23] Paul Schellhammer,et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.
[24] A. Heidenreich,et al. Anatomical extent of pelvic lymphadenectomy in patients undergoing radical prostatectomy. , 2007, European urology.
[25] B. Guillonneau,et al. Laparoscopic radical prostatectomy: contemporary comparison with open surgery. , 2007, Urologic oncology.
[26] L. Potters,et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[27] S Duke Herrell,et al. Robotic-assisted laparoscopic prostatectomy: what is the learning curve? , 2005, Urology.
[28] Anthony V D'Amico,et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. , 2007, The Journal of urology.
[29] A. Renshaw,et al. Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for clinically localized prostate cancer. , 2000, JAMA.
[30] Andrew J Vickers,et al. The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort study. , 2009, The Lancet. Oncology.
[31] L. Kavoussi,et al. Tumor seeding in urological laparoscopy: an international survey. , 2004, The Journal of urology.
[32] J. Crook,et al. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] J. Ciezki,et al. Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer. , 2009, International journal of radiation oncology, biology, physics.
[34] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[35] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[36] P. Grimm,et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. , 1999, International journal of radiation oncology, biology, physics.